Snowflake Inc vs Stryker Corporation — how do they compare? Snowflake Inc trades at $331.48 (market cap $116.95B), while Stryker Corporation trades at $277.44 (market cap $105.63B). The key difference: Snowflake Inc and Stryker Corporation are close in size by market cap, and Stryker Corporation pays a 1.28% dividend while Snowflake Inc pays none. Which is the better fit depends on your goals.
| SNOW | SYK | |
|---|---|---|
Market Cap | $116.95B | $105.63B |
Sector | Technology | Technology |
52-Week High | $356.47 | $388.79 |
52-Week Low | $121.11 | $275.39 |
Enterprise Value | $117.37B | $117.10B |
Dividend Yield | — | 1.28% |
Signals from Pluang's Aura AI — not financial advice
Snowflake (SNOW) trades at $335.50, down 0.5% on the day, following a strong earnings-driven rally. The stock exhibits bullish technical signals with support at $331 and resistance at $340. Revenue growth accelerated to 37% year-over-year in Q2 2026, with consistent earnings beats, though profitability remains negative with a net margin of -20.07%. Recent news highlights AI-driven demand boosting product revenue and customer adoption.
Outlook is positive with 81% analyst buy ratings and a $430.10 price target, reflecting optimism around AI data cloud growth. Key risks include high valuation (P/S 21.25), persistent losses, and competitive pressures. Investors should weigh growth potential against profitability challenges and market volatility.
Stryker Corporation (SYK) trades at $276.43, down 8.81% over 24 hours, reflecting bearish technical signals but strong fundamentals. The stock shows robust profitability with a 14.43% net income margin and consistent earnings beats in recent quarters. Recent developments include the launch of an FDA-cleared surgical app for Apple Vision Pro and the acquisition of ZuriMED to expand shoulder care offerings. Analyst consensus remains strongly bullish with a $372.89 price target, though ongoing securities fraud investigations pose near-term sentiment risks.
Outlook is positive long-term due to solid financial health, innovation pipeline, and institutional support, but investors face volatility from legal probes and technical bearishness. The stock's current dip may present a buying opportunity for those confident in Stryker's market position and growth trajectory, balanced against regulatory and market risks.
Trailing returns across standard periods
Latest headlines on both assets
Founded in 2012, Snowflake is a data lake, warehousing, and sharing company that came public in 2020. To date, the company has over 3,000 customers including nearly 30% of the Fortune 500 as its customers. Snowflake's data lake stores unstructured and semistructured data that can then be used in analytics to create insights stored in its data warehouse. Snowflake's data sharing capability allows enterprises to easily buy and ingest data almost instantaneously compared with a traditionally months-long process. Overall, the company is known for the fact that all of its data solutions that can be hosted on various public clouds.
Read more on SNOW →Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →